Literature DB >> 11711840

Latanoprost-induced iris heterochromia and open-angle glaucoma: a clinicopathologic report.

J C Tsai1, J A Sivak-Callcott, B G Haik, J Zhang, I W McLean.   

Abstract

PURPOSE: To report the histopathologic and immunohistochemical findings from the iridectomy specimen of a patient with acquired unilateral iris heterochromia due to latanoprost. PATIENT AND METHODS: A 45-year-old woman with open-angle glaucoma and unilateral iris heterochromia was evaluated for uncontrolled intraocular pressure increase. Subsequently, the patient underwent trabeculectomy with mitomycin C and an iridectomy specimen was obtained for analysis.
RESULTS: The histopathologic analysis of the iridectomy specimen did not reveal any nuclear atypia, nuclear crowding, or mitotic figures. Immunohistochemical studies showed that the iris melanocytes were negative for HMB45 and S-100, and weakly positive for Melan A.
CONCLUSION: Latanoprost-associated iris color change may exhibit a diffuse, uniform, dark velvet-brown appearance, thereby simulating diffuse iris melanoma. Histopathologic and immunohistochemical analysis confirmed the benign characteristics of the affected iris melanocytes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11711840     DOI: 10.1097/00061198-200110000-00009

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  4 in total

1.  Incidence of a latanoprost-induced increase in iris pigmentation in Japanese eyes.

Authors: 
Journal:  Jpn J Ophthalmol       Date:  2006 Mar-Apr       Impact factor: 2.447

2.  A study of histopathological features of latanoprost-treated irides with or without darkening compared with non-latanoprost-treated irides.

Authors:  Daniel M Albert; Ronald E Gangnon; Hans E Grossniklaus; W Richard Green; Soesiawati Darjatmoko; Amol D Kulkarni
Journal:  Arch Ophthalmol       Date:  2008-05

3.  Anterior Segment Optical Coherence Tomography Analysis of Iris Morphometric Changes Induced by Prostaglandin Analogues Treatment in Patients with Primary Open Angle Glaucoma or Ocular Hypertension.

Authors:  R Mancino; E Di Carlo; D Napoli; A Martucci; A Mauro; Sorge Rp; M Cesareo; C Nucci
Journal:  Open Ophthalmol J       Date:  2018-06-29

4.  [Relative contraindication of latanoprost in iris tumors with secondary glaucoma].

Authors:  S J Fröhlich; A J Mueller; A Kampik
Journal:  Ophthalmologe       Date:  2003-08       Impact factor: 1.059

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.